About
Technology
Issues
FAQ
Search
Scientometrics
Impact Factor
Discipline Ranks
h
-index
g
-index
Articles
Citations
Article Citations
Citation Distribution
Overviews
Top Institutions
Top Schools
Top Authors
Prolific Authors
Top Articles
Citing Bodies
Top Citing Authors
Top Citing Institutions
Top Citing Schools
Top Citing Journals
Top Citing Disciplines
exaly
›
Journals
›
Pharmaceutical Development and Technology
›
top-articles
Pharmaceutical Development and Technology
2.9
(top 20%)
impact factor
2.3K
(top 10%)
papers
40.0K
(top 10%)
citations
68
(top 10%)
h
-index
3.0
(top 20%)
impact factor
2.5K
all documents
41.9K
doc citations
95
(top 10%)
g
-index
Top Articles
#
Title
Journal
Year
Citations
1
Protein Stability During Freezing: Separation of Stresses and Mechanisms of Protein Stabilization
Pharmaceutical Development and Technology
2007
368
2
Micron‐Size Drug Particles: Common and Novel Micronization Techniques
Pharmaceutical Development and Technology
2004
284
3
Mucoadhesive DL-Lactide/Glycolide Copolymer Nanospheres Coated with Chitosan to Improve Oral Delivery of Elcatonin
Pharmaceutical Development and Technology
2000
217
4
The Effect of Operating and Formulation Variables on the Morphology of Spray-Dried Protein Particles
Pharmaceutical Development and Technology
1997
206
5
Stabilization of Pharmaceuticals to Oxidative Degradation
Pharmaceutical Development and Technology
2002
206
6
A proposal for a drug product Manufacturing Classification System (MCS) for oral solid dosage forms
Pharmaceutical Development and Technology
2015
192
7
Solventless Pharmaceutical Coating Processes: A Review
Pharmaceutical Development and Technology
2007
170
8
Performance of Sonication and Microfluidization for Liquid–Liquid Emulsification
Pharmaceutical Development and Technology
1999
162
9
Properties of Sustained-Release Tablets Prepared by Hot-Melt Extrusion
Pharmaceutical Development and Technology
1999
155
10
Rheological and mechanical properties of poloxamer mixtures as a mucoadhesive gel base
Pharmaceutical Development and Technology
2011
140
11
A biopharmaceutical classification-based Right-First-Time formulation approach to reduce human pharmacokinetic variability and project cycle time from First-In-Human to clinical Proof-Of-Concept
Pharmaceutical Development and Technology
2012
138
12
Supercritical fluid technology: a promising approach in pharmaceutical research
Pharmaceutical Development and Technology
2013
130
13
Ocular ciprofloxacin hydrochloride mucoadhesive chitosan-coated liposomes
Pharmaceutical Development and Technology
2011
123
14
Cyclodextrin-based nanosponges: effective nanocarrier for Tamoxifen delivery
Pharmaceutical Development and Technology
2013
123
15
Hydrolysis in Pharmaceutical Formulations
Pharmaceutical Development and Technology
2002
121
16
Aqueous solubility of crystalline and amorphous drugs: Challenges in measurement
Pharmaceutical Development and Technology
2011
118
17
In Situ Salt Screening-A Useful Technique for Discovery Support and Preformulation Studies
Pharmaceutical Development and Technology
1998
117
18
Evaluation of the Nano Spray Dryer B-90 for pharmaceutical applications
Pharmaceutical Development and Technology
2011
115
19
Physical Characterization of Pharmaceutical Formulations in Frozen and Freeze-Dried Solid States: Techniques and Applications in Freeze-Drying Development
Pharmaceutical Development and Technology
2006
114
20
Deep eutectic solvents for pharmaceutical formulation and drug delivery applications
Pharmaceutical Development and Technology
2020
111
21
Why is mannitol becoming more and more popular as a pharmaceutical excipient in solid dosage forms?
Pharmaceutical Development and Technology
2014
109
22
Practical fundamentals of glass, rubber, and plastic sterile packaging systems
Pharmaceutical Development and Technology
2010
108
23
Influence of Peroxide Impurities in Povidone and Crospovidone on the Stability of Raloxifene Hydrochloride in Tablets: Identification and Control of an Oxidative Degradation Product
Pharmaceutical Development and Technology
2000
106
24
Excipients for Direct Compaction—an Update
Pharmaceutical Development and Technology
2006
105
25
PLGA micro and nanoparticles in delivery of peptides and proteins; problems and approaches
Pharmaceutical Development and Technology
2015
105
26
Enhancement of oral bioavailability of atorvastatin calcium by self-emulsifying drug delivery systems (SEDDS)
Pharmaceutical Development and Technology
2011
104
27
Dissolution Rate Enhancement by Adsorption of Poorly Soluble Drugs on Hydrophilic Silica Aerogels
Pharmaceutical Development and Technology
2005
102
28
Formulation of Proteins in Vacuum-Dried Glasses. II. Process and Storage Stability in Sugar-Free Amino Acid Systems
Pharmaceutical Development and Technology
1999
101
29
Formulation development and process analysis of drug-loaded filaments manufactured via hot-melt extrusion for 3D-printing of medicines
Pharmaceutical Development and Technology
2018
101
30
In Situ Dehydration of Carbamazepine Dihydrate: A Novel Technique to Prepare Amorphous Anhydrous Carbamazepine
Pharmaceutical Development and Technology
2000
100
31
Sonication Parameters for the Preparation of Biodegradable Nanocapsulesof Controlled Size by the Double Emulsion Method
Pharmaceutical Development and Technology
2003
100
32
Co-solvent solubilization of some poorly-soluble antidiabetic drugs
Pharmaceutical Development and Technology
2009
100
33
Improvement of Solubility and Oral Bioavailability of Rutin by Complexation with 2-Hydroxypropyl-β-cyclodextrin
Pharmaceutical Development and Technology
2000
99
34
Curcumin-containing chitosan nanoparticles as a potential mucoadhesive delivery system to the colon
Pharmaceutical Development and Technology
2013
99
35
Tamoxifen Citrate Loaded Solid Lipid Nanoparticles (SLN™): Preparation, Characterization, In Vitro Drug Release, and Pharmacokinetic Evaluation
Pharmaceutical Development and Technology
2006
94
36
Real-time assessment of critical quality attributes of a continuous granulation process
Pharmaceutical Development and Technology
2013
94
37
Polyacrylic acid polymers hydrogels intended to topical drug delivery: preparation and characterization
Pharmaceutical Development and Technology
2015
94
38
Identifying the Stable Polymorph Early in the Drug Discovery–Development Process
Pharmaceutical Development and Technology
2005
93
39
Influence of Elastic Deformation of Particles on Heckel Analysis
Pharmaceutical Development and Technology
2001
92
40
Freeze‐Drying of Mannitol–Trehalose–Sodium Chloride‐Based Formulations: The Impact of Annealing on Dry Layer Resistance to Mass Transfer and Cake Structure
Pharmaceutical Development and Technology
2004
92
41
Preparation and Characterization of Agarose Hydrogel Nanoparticles for Protein and Peptide Drug Delivery
Pharmaceutical Development and Technology
1997
89
42
Enhanced Drug Dissolution and Bulk Properties of Solid Dispersions Granulated with a Surface Adsorbent
Pharmaceutical Development and Technology
2001
89
43
Sulforaphane delivery using mPEG–PCL co-polymer nanoparticles to breast cancer cells
Pharmaceutical Development and Technology
2017
88
44
Practical Formulation and Process Development of Freeze-Dried Products
Pharmaceutical Development and Technology
2005
86
45
Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route
Pharmaceutical Development and Technology
2015
84
46
Positively Charged Self-Emulsifying Oil Formulation for Improving Oral Bioavailability of Progesterone
Pharmaceutical Development and Technology
1996
83
47
Polymeric nanosponges as an alternative carrier for improved retention of econazole nitrate onto the skin through topical hydrogel formulation
Pharmaceutical Development and Technology
2011
83
48
Production of Eudragit Microparticles by Spray-Drying Technique: Influence of Experimental Parameters on Morphological and Dimensional Characteristics
Pharmaceutical Development and Technology
2000
82
49
Curcumin amorphous solid dispersions: the influence of intra and intermolecular bonding on physical stability
Pharmaceutical Development and Technology
2014
82
50
Multivariate analysis in the pharmaceutical industry: enabling process understanding and improvement in the PAT and QbD era
Pharmaceutical Development and Technology
2015
80
site/software ©
exaly
; All materials licenced under
CC by-SA
.